English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Journal Compilation © 2011 Acta Dermato-Venereologica. ISSN 0001-5555 Pazufloxacin mesilate is an injectable fluoroquinolone antibiotic with a broad spectrum of antibacterial activity that includes Gram-negative bacteria in particular (1). Its therapeutic use was approved by the Japanese govern ment in 2002, and its intravenous administration is effective for respiratory infections, liver abscess, pyelonephritis and other conditions. While diarrhoea and vomiting occur occasionally as adverse effects of pazufloxacin, cutaneous side-effects have not been reported in the English literature. We report here a case of generalized fixed drug eruption caused by pazufloxacin.

Generalized Fixed Drug Eruption Caused by Pazufloxacin